SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-16-033635
Filing Date
2016-06-10
Accepted
2016-06-10 07:18:24
Documents
5
Effectiveness Date
2016-06-10

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A dffn20160606_defa14a.htm DEFA14A 17076
2 a4.jpg GRAPHIC 8348
3 a3.jpg GRAPHIC 25820
4 a2.jpg GRAPHIC 76753
5 a1.jpg GRAPHIC 57792
  Complete submission text file 0001437749-16-033635.txt   251203
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-24477 | Film No.: 161707369
SIC: 2834 Pharmaceutical Preparations